Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model

Critical Care

Volumn 15, Issue 3, 2011, Pages

  Ader, Florence ^a,b   Jawhara, Samir ^c   Nseir, Saad ^c   Kipnis, Eric ^c   Faure, Karine ^c   Vuotto, Fanny ^c   Chemani, Chanez ^c   Sendid, Boualem ^c   Poulain, Daniel ^c   Guery, Benoit ^c  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CANDIDA ALBICANS; CANDIDIASIS; ENDOTHELIUM INJURY; FUNGAL COLONIZATION; HISTOPATHOLOGY; LUNG ENDOTHELIUM; LUNG INJURY; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; ANIMAL; BACTERIAL COUNT; BAGG ALBINO MOUSE; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSEUDOMONAS INFECTION; RANDOMIZATION; TIME;

ANIMALS; BACTERIAL LOAD; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; LUNG INJURY; MICE; MICE, INBRED BALB C; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RANDOM ALLOCATION; TIME FACTORS;

EID: 79959246314     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10276     Document Type: Article

References (33)

1. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005, 33:2184-2193. 10.1097/01.CCM.0000181731.53912.D9, 16215368.
2. Markowicz P, Wolff M, Djedaini K, Cohen Y, Chastre J, Delclaux C, Merrer J, Herman B, Veber B, Fontaine A, Dreyfuss D. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 2000, 161:1942-1948. 10852771, 10852771 .
3. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
4. Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, Rodino FJ. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006, 129:1210-1218. 10.1378/chest.129.5.1210, 16685011.
5. el-Ebiary M, Torres A, Fabregas N, de la Bellacasa JP, González J, Ramirez J, del Baño D, Hernández C, Jiménez de Anta MT. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients: an immediate post-mortem histologic study. Am J Respir Crit Care Med 1997, 156:583-590.
6. Wood GC, Mueller EW, Croce MA, Boucher BA, Fabian TC. Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients. Intensive Care Med 2006, 32:599-603. 10.1007/s00134-005-0065-6, 16477410, 16477410 .
7. Delisle MS, Williamson DR, Perreault MM, Albert M, Jiang X, Heyland DK. The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care 2008, 23:11-17. 10.1016/j.jcrc.2008.01.005, 18359416.
8. Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, Adrie C, Garrouste-Orgeas M, Cohen Y, Mourvillier B, Schlemmer B, . Outcomerea Study Group Candida colonization of the respiratory tract and subsequent Pseudomonas ventilator-associated pneumonia. Chest 2006, 129:110-117. 10.1378/chest.129.1.110, 16424420, Outcomerea Study Group.
9. Nseir S, Jozefowicz E, Cavestri B, Sendid B, Di Pompeo C, Dewavrin F, Favory R, Roussel-Delvallez M, Durocher A. Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med 2007, 33:137-142. 10.1007/s00134-006-0422-0, 17115135.
10. Adair CG, Gorman SP, Feron BM, Byers LM, Jones DS, Goldsmith CE, Moore JE, Kerr JR, Curran MD, Hogg G, Webb CH, McCarthy GJ, Milligan KR. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999, 25:1072-1076. 10.1007/s001340051014, 10551961.
11. El-Azizi MA, Starks SE, Khardori N. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J Appl Microbiol 2004, 96:1067-1073. 10.1111/j.1365-2672.2004.02213.x, 15078523.
12. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003, 11:30-36. 10.1016/S0966-842X(02)00002-1, 12526852.
13. Hogan DA, Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 2002, 296:2229-2232. 10.1126/science.1070784, 12077418.
14. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 2004, 54:1212-1223. 10.1111/j.1365-2958.2004.04349.x, 15554963.
15. Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol Med Microbiol 2010, 59:493-503. 2936118, 20608978.
16. Roux D, Gaudry S, Dreyfuss D, El-Benna J, de Prost N, Denamur E, Saumon G, Ricard JD. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit Care Med 2009, 37:1062-1067. 10.1097/CCM.0b013e31819629d2, 19237918.
17. Chemani C, Imberty A, de Bentzmann S, Pierre M, Wimmerovà M, Guery BP, Faure K. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun 2009, 77:2065-2075. 10.1128/IAI.01204-08, 2681743, 19237519.
18. Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 1984, 198:179-182. 10.1007/BF00328721, 6394964.
19. Jayr C, Garat C, Meignan M, Pittet JF, Zelter M, Matthay MA. Alveolar liquid and protein clearance in anesthetized ventilated rats. J Appl Physiol 1994, 76:2636-2642. 10.1063/1.357560, 7928894.
20. Kwak YG, Song CH, Yi HK, Hwang GH, Kim PS, Lee KS, Lee YC. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 2003, 111:1083-1092. 152583, 12671058.
21. Fortier B, Hopwood V, Poulain D. Electric and chemical fusions for the production of monoclonal antibodies reacting with the in-vivo growth phase of Candida albicans. J Med Microbiol 1988, 27:239-245. 10.1099/00222615-27-4-239, 3058980.
22. Jawhara S, Thuru X, Standaert-Vitse A, Jouault T, Mordon S, Sendid B, Desreumaux P, Poulain D. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis 2008, 197:972-980. 10.1086/528990, 18419533.
23. Fujita K, Tateda K, Kimura S, Saga T, Ishi Y, Yamagushi K. A novel aspect of interspecies communication in Candida and Pseudomonas: co-existence of Candida modulates dissemination and lethality in P. aeruginosa pulmonary infection [abstract]. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2008, 187:B70.
24. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 1999, 104:743-750. 10.1172/JCI7124, 408437, 10491409.
25. Sawa T, Ohara M, Kurahashi K, Twining SS, Frank DW, Doroques DB, Long T, Gropper MA, Wiener-Kronish JP. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect Immun 1998, 66:3242-3249. 108338, 9632591.
26. Imberty A, Wimmerova M, Mitchell EP, Gilboa-Garber N. Structure of the lectins from Pseudomonas aeruginosa: insights into the molecular basis for host glycan recognition. Microb Infect 2004, 6:221-228.
27. Sundstrom P. Adhesion in Candida spp. Cell Microbiol 2002, 4:461-469. 10.1046/j.1462-5822.2002.00206.x, 12174081.
28. Filler SG. Candida-host cell receptor-ligand interactions. Curr Op Microbiol 2006, 9:333-339.
29. Hogan DA. Talking to themselves: autoregulation and quorum sensing in fungi. Eukaryotic Cell 2006, 5:613-619. 10.1128/EC.5.4.613-619.2006, 1459667, 16607008.
30. Cugini C, Hogan DA. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol Microbiol 2007, 65:896-906. 10.1111/j.1365-2958.2007.05840.x, 17640272.
31. McAlester G, O'Gara F, Morrissey JP. Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J Med Microbiol 2008, 57:563-569. 10.1099/jmm.0.47705-0, 18436588.
32. Londono P, Gao XM, Bowe F, McPheat WL, Booth G, Dougan G. Evaluation of the intranasal challenge route in mice as a mucosal model for Candida albicans infection. Microbiology 1998, 144:2291-2298. 10.1099/00221287-144-8-2291, 9720052.
33. Molliex S, Montravers P, Dureuil B, Desmonts JM. Halogenated anesthetics inhibit Pseudomonas aeruginosa growth in culture conditions reproducing the alveolar environment. Anesth Analg 1998, 86:1075-1078.